Date published: 2026-6-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

IRS-2 Activators

Insulin receptor substrate 2 (IRS-2) is a critical adaptor protein involved in signal transduction downstream of various receptor tyrosine kinases, particularly insulin and insulin-like growth factor 1 (IGF-1) receptors. Upon activation of these receptors by their respective ligands, IRS-2 becomes phosphorylated on multiple tyrosine residues, leading to the recruitment and activation of downstream signaling molecules. The primary function of IRS-2 is to relay extracellular signals to intracellular pathways involved in cell growth, survival, metabolism, and differentiation.

Activation of IRS-2 typically involves phosphorylation events initiated by ligand binding to receptor tyrosine kinases. Upon ligand binding, IRS-2 becomes phosphorylated at specific tyrosine residues, creating docking sites for proteins containing Src homology 2 (SH2) domains. These proteins, such as phosphatidylinositol 3-kinase (PI3K) and growth factor receptor-bound protein 2 (Grb2), bind to IRS-2 and propagate downstream signaling cascades. PI3K activation leads to the generation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which in turn activates protein kinase B (Akt) and promotes cell survival and growth. Additionally, Grb2 binding to IRS-2 facilitates the activation of the Ras-Raf-MAP kinase pathway, which regulates cell proliferation and differentiation. Overall, activation of IRS-2 orchestrates a complex network of signaling events that regulate various cellular processes crucial for organismal homeostasis and development.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SC 26196

218136-59-5sc-361350
sc-361350A
10 mg
50 mg
$158.00
$630.00
3
(0)

PI3K inhibitor influencing the PI3K/Akt pathway. SC-26196 may indirectly modulate IRS-2 by suppressing the PI3K/Akt pathway, impacting IRS-2 activation and downstream signaling.

BMS-536924

468740-43-4sc-507397
5 mg
$285.00
(0)

IGF-1R/IR inhibitor affecting IRS-2 phosphorylation. BMS-536924 may directly influence IRS-2 by inhibiting its phosphorylation through the IGF-1R/IR pathway, thereby modulating downstream effects.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor affecting PI3K/Akt signaling. Wortmannin may indirectly modulate IRS-2 by interfering with the PI3K/Akt pathway, impacting IRS-2 activation and downstream cellular responses.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor affecting MAPK/ERK and PI3K/Akt pathways. Sorafenib may potentially modulate IRS-2 by influencing both MAPK/ERK and PI3K/Akt pathways, impacting IRS-2 activation.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$224.00
$386.00
5
(1)

ERK inhibitor impacting the MAPK/ERK pathway. BIX02189 may potentially modulate IRS-2 by selectively inhibiting ERK signaling, influencing IRS-2 activation and downstream cellular responses.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor affecting inflammatory signaling. SB203580 can potentially impact IRS-2 by suppressing the p38 MAPK pathway, a regulator of IRS-2 activation and downstream signaling events.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor affecting the JNK pathway. SP600125 can potentially modulate IRS-2 by suppressing the JNK pathway, impacting IRS-2 activation and downstream cellular responses.